4.3 Article

Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjects

S. F. La Vincente et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)

Article Pharmacology & Pharmacy

Transcriptional and translational regulation of glial activation by morphine in a rodent model of neuropathic pain

VL Tawfik et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)

Article Pharmacology & Pharmacy

Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy

V Raghavendra et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)

Article Pharmacology & Pharmacy

Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats

KJ Powell et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)

Article Neurosciences

The involvement of glial cells in the development of morphine tolerance

P Song et al.

NEUROSCIENCE RESEARCH (2001)

Article Pharmacology & Pharmacy

Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs

C Gouardères et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2000)